Diptera Larvae Extract for Wound Debridement

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current wound healing treatments face challenges such as delayed healing due to inadequate granulation tissue formation, adverse reactions to proteolytic enzymes, and logistical issues with live maggots, including pain, microbial contamination, and storage difficulties, as well as the lack of effective and stable wound-healing extracts from Diptera.

Innovation Solution

A wound healing composition is developed using extracts from Diptera larvae, where proteolytic activity is removed through heat treatment and ultrafiltration to retain substances with molecular masses between 500 and 10,000 daltons, which are then sterilized and lyophilized for stable storage and application, minimizing immunological side effects and microbial contamination.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If live maggots are used for wound debridement, then necrotic tissue removal is effective, but patient pain and microbial contamination risk increase

Engineering Contradiction:
Improvewound debridement effectivenessVSAvoidpatient pain and microbial contamination
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The invention extracts the beneficial proteolytic substances from live maggots and formulates them into a topical cream preparation. This separates the therapeutic function (necrotic tissue debridement) from the harmful aspects (patient pain, microbial contamination risk) by using a controlled pharmaceutical formulation instead of live organisms.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention creates an artificial copy of the maggot's therapeutic effect by isolating and reproducing its proteolytic enzymes in a controlled cream formulation. This copy maintains the debridement functionality while eliminating the need for live maggots and their associated drawbacks.

Inventive Principle:
Principle #26Copying

2Productivity

If proteolytic enzymes from bacteria or animals are used, then wound cleaning is achieved, but effectiveness is reduced due to short half-life and limited activity spectrum

Engineering Contradiction:
Improvewound cleaning capabilityVSAvoidenzyme stability and activity spectrum
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The invention changes the source parameter of the proteolytic enzymes from conventional bacterial or animal sources to Diptera larvae (maggot) derived enzymes. This parameter change provides enzymes with a broader activity spectrum and improved stability characteristics suitable for wound debridement applications.

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If live maggots are transported and stored, then therapeutic application is possible, but growth control and pathogen contamination become problematic

Engineering Contradiction:
Improvetherapeutic application availabilityVSAvoidgrowth control and pathogen-free status
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The invention performs preliminary action by harvesting, processing, and formulating maggot proteolytic enzymes into a stable cream preparation in advance. This allows the therapeutic substance to be stored and transported in a controlled, stable form without the complications of live maggot growth and pathogen management.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The invention replaces the need for carefully managed live biological organisms with a stable, shelf-ready pharmaceutical cream formulation. This disposable-like preparation can be stored, transported, and applied without the ongoing biological management requirements of live maggots.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition effectively accelerates wound healing by promoting debridement and tissue repair without causing inflammation, is easily standardized and dosed, and can be stored for prolonged use, addressing the limitations of existing treatments.

Implementation Method 1

proteolytic activity is removed through heat treatment

Methodology Applied
Scientific EffectHeat treatment: Heating

Implementation Method 2

ultrafiltration to retain substances with molecular masses between 500 and 10,000 daltons

Methodology Applied
Scientific EffectUltrafiltration: Filter (physical)

Implementation Method 3

lyophilized for stable storage

Methodology Applied
Scientific EffectLyophilization: Freeze Drying

Data Source

PatentEP1965815B1Wound healing composition comprising substances obtained from diptera larvae
Publication Date: 2016.02.24 ALPHA BIOCARE

AI summary

Disclosed is a wound healing composition comprising a mixture of substances that are obtained from diptera larvae, are heat-resistant at 100 °C, and have molecular weights ranging from 500 to 10,000 Dalton. Also disclosed are the use of said composition as well as a method for the production thereof.